Robust individual circadian parameter estimation for biosignal-based personalisation of cancer chronotherapy

In cancer treatment, chemotherapy is administered according a constant schedule. The chronotherapy approach, considering chronobiological drug delivery, adapts the chemotherapy profile to the circadian rhythms of the human organism. This reduces toxicity effects and at the same time enhances efficiency of chemotherapy. To personalize cancer treatment, chemotherapy profiles have to be further adapted to individual patients. Therefore, we present a new model to represent cycle phenomena in circadian rhythms. The model enables a more precise modelling of the underlying circadian rhythms. In comparison with the standard model, our model delivers better results in all defined quality indices. The new model can be used to adapt the chemotherapy profile efficiently to individual patients. The adaption to individual patients contributes to the aim of personalizing cancer therapy.

[1]  A. Gorbach,et al.  Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy , 2014, Chronobiology international.

[2]  J. Clairambault,et al.  A Systems Biomedicine Approach for Chronotherapeutics Optimization: Focus on the Anticancer Drug Irinotecan , 2012 .

[3]  Modelling targets for anticancer drug control optimization in physiologically structured cell population models , 2012 .

[4]  F. Lévi,et al.  Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics , 2011, Expert opinion on drug delivery.

[5]  F. Gachon,et al.  The role of circadian timing system on drug metabolism and detoxification , 2011, Expert opinion on drug metabolism & toxicology.

[6]  Stéphane Gaubert,et al.  Circadian rhythm and cell population growth , 2010, Math. Comput. Model..

[7]  Ki H Chon,et al.  Skin surface temperature rhythms as potential circadian biomarkers for personalized chronotherapeutics in cancer patients , 2011, Interface Focus.

[8]  F. Lévi,et al.  Chronotherapy and the molecular clock: Clinical implications in oncology. , 2010, Advanced drug delivery reviews.

[9]  Jean Clairambault,et al.  Circadian timing in cancer treatments. , 2010, Annual review of pharmacology and toxicology.

[10]  Pasquale F Innominato,et al.  Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches , 2009, Integrative cancer therapies.

[11]  J. A. Madrid,et al.  Circadian rhythm of wrist temperature in normal-living subjects A candidate of new index of the circadian system , 2008, Physiology & Behavior.

[12]  Ralf Mikut,et al.  Data Mining in der Medizin und Medizintechnik , 2008 .

[13]  Francis Lévi,et al.  Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. , 2007, Advanced drug delivery reviews.

[14]  Francis Lévi,et al.  Chronotherapeutics: The Relevance of Timing in Cancer Therapy , 2006, Cancer Causes & Control.

[15]  F. Lévi,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[16]  Giuseppe Tonini,et al.  Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.

[17]  Francis Lévi,et al.  Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.

[18]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.